Our comparative cohort study, carried out between 3rd January and 30th April 2020, looked at the maternal and perinatal outcomes associated with pre-eclampsia. Of 2019 booked pregnant women, 141 (7.0%) had pre-eclampsia, and 59.8% of these were severe at admission. Significant adverse maternal outcomes were eclampsia, HELLP (haemolysis, elevated liver enzymes, and low platelets) syndrome, and placental abruption, and significant adverse perinatal outcomes were intra-uterine fetal death, preterm delivery, low birth weight (LBW), neonatal asphyxia and early neonatal death. Close attention needs to be given to women with pre-eclampsia in poor resource circumstances.
GoldenbergRLMcClureEM. It takes a system: magnesium sulfate for prevention of eclampsia in a resource-limited community setting. Glob Health Sci Pract2019; 7: 340–343.
2.
BrownMAMageeLAKennyLC, et al.The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens2018; 13: 291–310.
3.
TandbergAKlungsøyrKRomundstad LB, et al.Pre-eclampsia and assisted reproductive technologies: consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG2015; 122: 915–922.
4.
MusaJMohammedCOchekeA, et al.Incidence and risk factors for pre-eclampsia in jos Nigeria. Afr Health Sci2018; 18: 584–595.
5.
HutcheonJALisonkovaSJosephKS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol2011; 25: 391–403.
6.
GrangerJPSpradleyFTBakraniaBA. The endothelin system: a critical player in the pathophysiology of preeclampsia. Curr Hypertens Rep2018; 20: 32.
7.
ShragaYParienteGRotemR, et al.Changes in trends over time for the specific contribution of different risk factors for pre-eclampsia. Arch Gynecol Obstet2020; 302: 977–982.
8.
ShamsiUHatcherJShamsiA, et al.A multicentre matched case control study of risk factors for preeclampsia in healthy women in Pakistan. BMC Womens Health2010; 10: 14.
9.
Hernández-ValenciaMSaldaña QuezadaLAlvarez MuñozM, et al.[Barrier family planning methods as risk factor which predisposes to preeclampsia] [Article in Spanish]. Ginecol Obstet Mex2000; 68: 333–338.
10.
AltmanDCarroliGDuleyL, et al.; magpie trial collaboration group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomized placebo-controlled trial. Lancet2002; 359: 1877–1890.
11.
McKenzieKATrotmanH. A retrospective study of neonatal outcome in preeclampsia at the university hospital of the west indies: a resource-limited setting. J Trop Pediatrics2019; 65: 78–83.
12.
IsmailKIHanniganAO’DonoghueK, et al.Abnormal placental cord insertion and adverse pregnancy outcomes: a systematic review and meta-analysis. Syst Rev2017; 6: 242.
13.
KieserMFriedeT. Re-calculating the sample size in internal pilot study designs with control of the type I error rate. Statist Med2000; 19: 901–911.
14.
OkwudireEGAtalabiOMEzenwugoUM. The use of uterine artery Doppler indices for prediction of pre-eclampsia in port-harcourt, Nigeria. Niger Postgrad Med J2019; 26: 223–229.
DekkerGA. Management of preeclampsia. Pregnancy Hyperten2014; 4: 246–247.
17.
ShoopalaHMHallDRRe-evaluation of abruptio placentae and other maternal complications during expectant management of early onset pre-eclampsia. Pregnancy Hypertens2019; 16: 38–41.
